Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behçet’s disease susceptibility

We analyzed 1,900 Turkish Behçet's disease cases and 1,779 controls genotyped with the Immunochip. The most significantly associated SNP was rs1050502, a tag SNP for HLA-B*51. In the Turkish discovery set, we identified three new risk loci, IL1A–IL1B, IRF8, and CEBPB–PTPN1, with genome-wide significance (P < 5 × 10−8) by direct genotyping and ADO–EGR2 by imputation. We replicated the ADO–EGR2, IRF8, and CEBPB–PTPN1 loci by genotyping 969 Iranian cases and 826 controls. Imputed data in 608 Japanese cases and 737 controls further replicated ADO–EGR2 and IRF8, and meta-analysis additionally identified RIPK2 and LACC1. The disease-associated allele of rs4402765, the lead marker at IL1A–IL1B, was associated with both decreased IL-1α and increased IL-1β production. ABO non-secretor genotypes for two ancestry-specific FUT2 SNPs showed strong disease association (P = 5.89 × 10−15). Our findings extend the list of susceptibility genes shared with Crohn's disease and leprosy and implicate mucosal factors and the innate immune response to microbial exposure in Behçet's disease susceptibility.

[1]  M. Jeannet,et al.  Letter: HL-A antigens in asymptomatic chronic HBAg carriers. , 1974, Lancet.

[2]  Y. Okada,et al.  Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy , 2015, Nature Genetics.

[3]  Christopher I. Amos,et al.  Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R/IL12RB2 regions associated with Behçet's disease , 2010, Nature Genetics.

[4]  A. Mirza,et al.  Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behçet's disease: an open-label pilot study , 2011, Annals of the rheumatic diseases.

[5]  M. Netea,et al.  Endogenous interleukin (IL)-1 alpha and IL-1 beta are crucial for host defense against disseminated candidiasis. , 2006, The Journal of infectious diseases.

[6]  F. Alkuraya,et al.  Study of Mendelian forms of Crohn's disease in Saudi Arabia reveals novel risk loci and alleles , 2014, Gut.

[7]  A. Silman,et al.  EULAR recommendations for the management of Behçet disease , 2008, Annals of the rheumatic diseases.

[8]  P. D. de Bakker,et al.  Behçet disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity , 2014, Proceedings of the National Academy of Sciences.

[9]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[10]  Nobuaki Yoshida,et al.  Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages , 1995, Cell.

[11]  O. Delaneau,et al.  A linear complexity phasing method for thousands of genomes , 2011, Nature Methods.

[12]  A. Uitterlinden,et al.  Genome-Wide Association Study in an Admixed Case Series Reveals IL12A as a New Candidate in Behçet Disease , 2015, PloS one.

[13]  K. Shianna,et al.  Long-range LD can confound genome scans in admixed populations. , 2008, American journal of human genetics.

[14]  A. Kijlstra,et al.  TNFAIP3 gene polymorphisms confer risk for Behcet’s disease in a Chinese Han population , 2012, Human Genetics.

[15]  M. Netea,et al.  Endogenous Interleukin (IL)–1α and IL-1β Are Crucial for Host Defense against Disseminated Candidiasis , 2006 .

[16]  S. Ohno,et al.  HLA-B*51 and Behçet Disease , 2012, Ocular immunology and inflammation.

[17]  H. Inoko,et al.  Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci , 2010, Nature Genetics.

[18]  L. Punzi,et al.  Biological Treatments in Behçet's Disease: Beyond Anti-TNF Therapy , 2014, Mediators of inflammation.

[19]  F. Al-Mohanna,et al.  Association of a Mutation in LACC1 With a Monogenic Form of Systemic Juvenile Idiopathic Arthritis , 2015, Arthritis & rheumatology.

[20]  R. Cortese,et al.  Lymphoproliferative disorder and imbalanced T‐helper response in C/EBP beta‐deficient mice. , 1995, The EMBO journal.

[21]  Javier Martín,et al.  Genetic Analysis with the Immunochip Platform in Behçet Disease. Identification of Residues Associated in the HLA Class I Region and New Susceptibility Loci , 2016, PloS one.

[22]  A. Kijlstra,et al.  IL-1β triggered by peptidoglycan and lipopolysaccharide through TLR2/4 and ROS-NLRP3 inflammasome-dependent pathways is involved in ocular Behçet's disease. , 2013, Investigative ophthalmology & visual science.

[23]  C. Cordon-Cardo,et al.  Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women. , 1989, The New England journal of medicine.

[24]  M. Peters,et al.  Systematic identification of trans eQTLs as putative drivers of known disease associations , 2013, Nature Genetics.

[25]  I. Sousa,et al.  FUT2: filling the gap between genes and environment in Behçet's disease? , 2015, Annals of the rheumatic diseases.

[26]  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. , 1990, Lancet.

[27]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[28]  Buhm Han,et al.  Imputing Amino Acid Polymorphisms in Human Leukocyte Antigens , 2013, PloS one.

[29]  Increased expression of the NLRP3 inflammasome components in patients with Behçet’s disease , 2015, Journal of Inflammation.

[30]  Philip Rosenstiel,et al.  Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype , 2011, Proceedings of the National Academy of Sciences.

[31]  H. Inoko,et al.  Immunology and functional genomics of Behçet's disease , 2003, Cellular and Molecular Life Sciences CMLS.

[32]  Alexander F. Wilson,et al.  Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behçet disease , 2013, Proceedings of the National Academy of Sciences.

[33]  P. Donnelly,et al.  A new multipoint method for genome-wide association studies by imputation of genotypes , 2007, Nature Genetics.

[34]  G. Hatemi,et al.  Frequency of pathergy phenomenon and other features of Behçet's syndrome among patients with inflammatory bowel disease. , 2008, Clinical and experimental rheumatology.

[35]  David C. Wilson,et al.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.

[36]  D. Altshuler,et al.  A map of human genome variation from population-scale sequencing , 2010, Nature.

[37]  S. Ohno,et al.  HL-A5 AND BEHCET'S DISEASE , 1973 .

[38]  P. Schirmacher,et al.  Fut2 genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis , 2014, Alimentary pharmacology & therapeutics.

[39]  M. Brown,et al.  Promise and pitfalls of the Immunochip , 2011, Arthritis research & therapy.

[40]  A. Bradley,et al.  C13orf31 (FAMIN) is a central regulator of immunometabolic function , 2016, Nature Immunology.

[41]  G T Ferguson,et al.  Recommendations for the management of COPD. , 2000, Chest.

[42]  M. Netea,et al.  Genomewide association study of leprosy. , 2010, The New England journal of medicine.

[43]  A. Pacheco,et al.  NOD2 and CCDC122-LACC1 genes are associated with leprosy susceptibility in Brazilians , 2014, Human Genetics.

[44]  Emily K. Tsang,et al.  The landscape of genomic imprinting across diverse adult human tissues , 2015, Genome research.

[45]  Manolis Kellis,et al.  HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants , 2011, Nucleic Acids Res..

[46]  Simon C. Potter,et al.  Mapping cis- and trans-regulatory effects across multiple tissues in twins , 2012, Nature Genetics.

[47]  D. Hu,et al.  Associations of FUT2 and FUT3 gene polymorphisms with Crohn's disease in Chinese patients , 2014, Journal of gastroenterology and hepatology.

[48]  O. Ozcebe,et al.  Behçet's disease. , 2019, The New England journal of medicine.

[49]  Tsun-Po Yang,et al.  Genevar: a database and Java application for the analysis and visualization of SNP-gene associations in eQTL studies , 2010, Bioinform..

[50]  J. Bertranpetit,et al.  A natural history of FUT2 polymorphism in humans. , 2009, Molecular biology and evolution.

[51]  G. Abecasis,et al.  Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies , 2006, Nature Genetics.

[52]  N. Bovin,et al.  Influence of the combined ABO, FUT2, and FUT3 polymorphism on susceptibility to Norwalk virus attachment. , 2005, The Journal of infectious diseases.

[53]  Pak Chung Sham,et al.  Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits , 2003, Bioinform..

[54]  Tariq Ahmad,et al.  Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci , 2010, Nature Genetics.

[55]  C. Wijmenga,et al.  Identification of multiple independent susceptibility loci in the HLA region in Behçet's disease , 2013, Nature Genetics.

[56]  P. Elias,et al.  Imiquimod-induced interleukin-1 alpha stimulation improves barrier homeostasis in aged murine epidermis. , 2004, The Journal of investigative dermatology.

[57]  S. Ohno,et al.  Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. , 1999, Tissue antigens.

[58]  J. Nikkilä,et al.  Secretor Genotype (FUT2 gene) Is Strongly Associated with the Composition of Bifidobacteria in the Human Intestine , 2011, PloS one.

[59]  Akira Meguro,et al.  Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1 , 2013, Nature Genetics.

[60]  Y. Mizushima Recent research into Behçet's disease in Japan. , 1988, International journal of tissue reactions.

[61]  L. Guillevin,et al.  HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies. , 2009, Arthritis and rheumatism.